Health-economic consequences of diabetic foot lesions

Clinical Infectious Diseases

Volumn 39, Issue SUPPL. 2, 2004, Pages

  Tennvall, Gunnel Ragnarson ^a   Apelqvist, Jan ^b  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

CONFERENCE PAPER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DATA BASE; DIABETIC FOOT; DRUG COST; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; LEG AMPUTATION; LONG TERM CARE; PATIENT EDUCATION; PRIORITY JOURNAL; REIMBURSEMENT; SHOE; SOCIAL BEHAVIOR; TOPICAL TREATMENT; ULCER HEALING;

AMPUTATION; COST OF ILLNESS; DIABETIC FOOT; HEALTH CARE COSTS; HUMANS;

EID: 3943071114     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383275     Document Type: Conference Paper

References (61)

1. American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care 1999; 22:1354-60.
2. International Working Group on the Diabetic Foot. International consensus on the diabetic foot. Amsterdam: The International Working Group on the Diabetic Foot, 1999.
3. Consensus statement. Foot problems of diabetics. Stockholm: Spri Publications, 1998.
4. Apelqvist J, Ragnarson Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995; 16:388-94.
5. Apelqvist J, Ragnarson Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235:463-71.
6. van Houtum WH, Lavery LA, Harkless LB. The costs of diabetes-related lower extremity amputations in the Netherlands. Diabet Med 1995; 12:777-81.
7. Johnson BF, Evans L, Drury R, Datta D, Morris-Jones W, Beard JD. Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits. Eur J Vasc Endovasc Surg 1995;9:181-8.
8. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 2000; 23:1333-8.
9. Holtzer SES, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Cost and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 1998; 20:169-1.
10. Panayiotopoulos YP, Tyrell MR, Arnold FJL, Korzon-Burakowska A, Amiel SA, Taylor PR. Results and cost analysis of distal (crural/pedal) arterial revascularisation for limb salvage in diabetic and non-diabetic patients. Diabet Med 1997; 14:214-20.
11. Metha SS, Suzuki S, Glick HA, Schulman KA. Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care 1999; 22:1110-5.
12. Palmer AJ, Weiss C, Sendi PP, et al. The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective. Diabetologia 2000; 43:13-26.
13. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22:382-7.
14. Singh S, Evans L, Datta D, Gaines P, Beard JD. The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg 1996; 12:359-62.
15. Van Acker K, Oleen-Burkey M, De Decker L, et al. Cost and resource utilization for prevention and treatment of foot lesions in a diabetic foot clinic in Belgium. Diabetes Res Clin Pract 2000; 50:87-95.
16. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995; 273:712-20.
17. Ragnarson Tennvall G, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000; 18:225-38.
18. Kobelt G. Health economics: an introduction to economic evaluation. London: Office of Health Economics, 1996.
19. Ragnarson Tennvall G, Apelqvist J. The inpatient care of patients with diabetes mellitus and foot ulcers: a validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations. J Intern Med 2000; 248:397-405.
20. Masson EA, MacFarlane IA, Power E, Wallymahmed M. An audit of the management and outcome of hospital inpatients with diabetes: resource planning implications for diabetes care team. Diabet Med 1992; 9:753-5.
21. Leslie PJ, Patrick AW, Hepburn DA, Scougal IJ, Frier BM. Hospital inpatient statistics underestimate the morbidity associated with diabetes mellitus. Diabet Med 1992; 9:379-85.
22. van Houtum WH, Lavery LA. Outcomes associated with diabetes-related amputations in the Netherlands and in the state of California, USA. J Intern Med 1996; 240:227-31.
23. US Bureau of Labor Statistics. Consumer price index, medical care. Vol 2000. Washington, DC: US Government Printing Office, 2000.
24. Landstingsförbundet. Statistisk årsbok för landsting 2000 [Statistical yearbook for county councils 2000] Stockholm: Landstingsfö rbundet (The Federation of County Councils), 2000.
25. Statistics Sweden. Statistical yearbook of Sweden, 2000. Stockholm: Statistics Sweden, 1999.
26. The Swedish Central Bank. Statistical yearbook 1998. Stockholm: The Swedish Central Bank, 1999.
27. Ashry HR, Lavery LA, Armstrong DG, Lavery DC, van Houtum WH. Cost of diabetes-related amputations in minorities. J Foot Ankle Surg 1998; 37:186-90.
28. Cheshire NJW, Wolfe JHN, Noone MA, Davies L, Drummond M. The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein. J Vasc Surg 1992; 15:167-75.
29. Gibbons GW, Marcaccio EJ, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs 1990: reduced length of stay and costs, insufficient reimbursement. Arch Surg 1993; 128:576-81.
30. Gupta SK, Veith FJ, Ascer E, White Flores SA, Gliedman ML. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis. Eur J Vasc Surg 1988; 2:151-4.
31. Statistics Sweden. Statistical yearbook of Sweden, 1993. Stockholm: Statistics Sweden, 1992.
32. Jägeblad G, Apelqvist J, Nyberg P, Berger B. The diabetic foot: from ulcer to multidisciplinary team approach - a process analysis [abstract]. In: The diabetic foot, third international symposium, Noordwijkerhout, The Netherlands, 1999: 149.
33. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med 1997; 14:867-70.
34. Mantey I, Foster AVM, Spencer S, Edmonds ME. Why do foot ulcers recur in diabetic patients? Diabet Med 1999; 16:245-9.
35. Mills JL, Beckett WC, Taylor SM. The diabetic foot: consequences of delayed treatment and referral. South Med J 1991; 84:970-4.
36. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 1989; 12:24-31.
37. Hill SL, Holtzman GI, Buse R. The effects of peripheral vascular disease with osteomyelitis in the diabetic foot. Am J Surg 1999; 177:282-6.
38. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16(Suppl 1):S75-83.
39. Herman WH, Eastman RC. The effects of treatment on the direct costs of diabetes. Diabetes Care 1998; 21(Suppl 3):C19-24.
40. Ollendorf DA, Kotsanos JG, Wishner WJ, et al. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 1998; 21:1240-5.
41. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 2001; 44:2077-87.
42. Patout CA, Birke JA, Horswell R, Williams D, Cerise FP. Effectiveness of a comprehensive diabetes lower-extremity amputation preventive program in a predominantly low-income African-American population. Diabetes Care 2000; 23:1339-42.
43. Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg 1998; 37:460-6.
44. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med 1998; 15:80-4.
45. Apelqvist J, Ragnarson Tennvall G. Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment; an economic analysis alongside a clinical trial. Acta Derm Venereol 1996; 76:231-5.
46. Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment. Diabetes Care 1999; 22:692-5.
47. Apelqvist J, Ragnarson Tennvall G, Larsson J. Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategies. Diabet Med 1995; 12:123-8.
48. Edmonds M, Gough A, Solovera J, Standaert B. Filgrastim in the treatment of infected diabetic foot ulcers: retrospective cost analysis of a phase II randomised clinical trial. Clinical Drug Investigation 1999; 17:275-86.
49. Ghatnekar O, Persson U, Willis M, Ödegaard K. Cost effectiveness of becaplermin in the treatment of diabetic foot ulcers in four European countries. Pharmacoeconomics 2001; 19:767-78.
50. Allenet B, Parée F, Lebrun T, et al. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the French context. Diabete Metab 2000; 26:125-32.
51. Persson U, Willis M, Ödegaard K, Apelqvist J. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data. Value in Health 2000; 3(Suppl 1):S39-46.
52. Benton GS, Kerstein MD. Cost effectiveness of early digit amputation in the patient with diabetes. Surg Gynecol Obstet 1985; 161:523-4.
53. Kerstein MD, Welter V, Gathan V, Roberts AB. Toe amputation in the diabetic patient. Surgery 1997; 122:546-7.
54. Birnbaum HG, Cremieux PY, Greenberg PE, LeLorier J, Ostrander J, Vendetti L. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999; 16:1-8.
55. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA, Fylling CP. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care 1997; 10:33-8.
56. Complications of diabetes: screening for retinopathy. Management of foot ulcers. Vol 5 York, UK: University of York, National Health Service Centre for Reviews and Dissemination, 1999.
57. Mason J, O'Keeffe C, McIntosh A, Hutchinson A, Booth A, Young RJ. A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I: prevention. Diabet Med 1999; 16:801-12.
58. Connor H. Diabetic foot disease: where is the evidence? Diabet Med 1999; 16:799-800.
59. Larsson J, Apelqvist J, Agardh CD, Stenström A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995; 12:770-6.
60. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990; 13:513-21.
61. Cavanagh PR, Ulbrecht JS, Caputo GM. The non-healing diabetic foot wound: fact or fiction? Ostomy Wound Manage 1998; 44(Suppl 3A): 6S-12S.